Pharmaron Beijing (HKG:3759, SHE:300759) reported a net profit attributable to owners of 308.4 million yuan for the quarter ended Sept. 30, a 12.62% drop from the previous year's quarter, according to a Tuesday filing with the Hong Kong bourse.
Earnings per share were 0.1744 yuan, a decline of 12.93% from a year earlier.
Revenue for the quarter increased 10.02% on-year to 3.21 billion yuan, according to the filing.
Price (HKD): $15.82, Change: $-0.60, Percent Change: -3.65%
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。